Outsourced Pharma Capacity Update Videos - Small Molecule

1. Ropack Pharma Solutions Capacity Update October 2025: Small Molecule 10/16/2025

   For clinical trials, we provide full support from warehousing to returns. Join Ropack's Head of Commercial, Chris Vounasis, for a presentation on our technologies and 2025–2026 capacity.

2. Pfizer CentreOne Oral Solids Capacity Update October 2025: Small Molecule 10/16/2025

   With specialized technologies like laser drilling, multilayer coating, and orally disintegrating tablets, our state-of-the-art facilities provide the precise infrastructure to support your most demanding OSD requirements.

3. Lonza Capacity Update October 2025: Small Molecule 10/16/2025

   Get an overview of our AI-assisted early phase toolkit, which combines predictive modeling, formulation screening, and data-driven insights to accelerate molecule progression.

4. Douglas CDMO Capacity Update October 2025: Small Molecule 10/16/2025

   Choose an experienced CDMO specializing in high-potency softgels and liquids to ensure high-quality products, responsive service, and reliable solutions across complex therapeutic areas.

5. Alcami Capacity Update October 2025: Small Molecule 10/16/2025

   Partner with a flexible, high-quality manufacturing expert to accelerate your bench-to-clinic journey, strengthen supply chain, and ensure seamless commercialization of oral solid dose therapies.

6. Upperton Pharma Solutions Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form 7/29/2025

   Ian Lafferty, CTO, and Josh Moule, Business Development Manager, talk through Upperton’s capabilities, project management approach and provide a virtual tour of their 60,000 sq. ft development and manufacturing facility.

7. Quotient Sciences Capacity Update July 2025 7/29/2025

   Explore how expedited review pathways can be strategically used to accelerate development while mitigating CMC risks.

8. PCI Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form 7/29/2025

   Dr. Rebecca Coutts highlights PCI’s high potent oral solid dose (OSD) and oral liquid capabilities, focusing on site expertise, specialized infrastructure, and handling of complex molecules.

9. Your Boutique CDMO Partner Of Choice 7/29/2025

   Lora Wallis and Chris Cuthbertson highlight Douglas CDMO’s strengths in high-potency softgels and liquids and the company's 67 years of expertise and a client-centric approach.

10. Comprehensive CDMO Services From Clinical To Commercial Supply 7/29/2025

    From world-class facilities across North America and Asia, high-quality drug products are manufactured and supplied to over 100 global markets, supporting patient and healthcare needs.